NCT02819843 2025-01-29A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid TumorsMemorial Sloan Kettering Cancer CenterPhase 2 Completed19 enrolled 7 charts